Thijs LG - Search Results

1

C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.

Hack CE, Ogilvie AC, Eisele B, Eerenberg AJ, Wagstaff J, Thijs LG. Hack CE, et al. Among authors: thijs lg. Intensive Care Med. 1993;19 Suppl 1:S19-28. doi: 10.1007/BF01738946. Intensive Care Med. 1993. PMID: 8053997 Review.

2

A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2.

Ogilvie AC, Baars JW, Eerenberg AJ, Hack CE, Pinedo HM, Thijs LG, Wagstaff J. Ogilvie AC, et al. Among authors: thijs lg. Br J Cancer. 1994 Mar;69(3):596-8. doi: 10.1038/bjc.1994.109. Br J Cancer. 1994. PMID: 8123494 Free PMC article.

3

Coagulation disorders in septic shock.

Thijs LG, de Boer JP, de Groot MC, Hack CE. Thijs LG, et al. Intensive Care Med. 1993;19 Suppl 1:S8-15. doi: 10.1007/BF01738944. Intensive Care Med. 1993. PMID: 8227738 Review.

4

Time course of cytokine levels in sepsis.

Thijs LG, Hack CE. Thijs LG, et al. Intensive Care Med. 1995 Nov;21 Suppl 2:S258-63. doi: 10.1007/BF01740764. Intensive Care Med. 1995. PMID: 8636533 Review.

5

Interplay of complement and cytokines in the pathogenesis of septic shock.

de Boer JP, Wolbink GJ, Thijs LG, Baars JW, Wagstaff J, Hack CE. de Boer JP, et al. Among authors: thijs lg. Immunopharmacology. 1992 Sep-Oct;24(2):135-48. doi: 10.1016/0162-3109(92)90019-9. Immunopharmacology. 1992. PMID: 1473964 Review.

6

Interleukin-8 in sepsis: relation to shock and inflammatory mediators.

Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA. Hack CE, et al. Among authors: thijs lg. Infect Immun. 1992 Jul;60(7):2835-42. doi: 10.1128/iai.60.7.2835-2842.1992. Infect Immun. 1992. PMID: 1612748 Free PMC article.

7

Plasma lipid peroxides and antioxidants in human septic shock.

Ogilvie AC, Groeneveld AB, Straub JP, Thijs LG. Ogilvie AC, et al. Among authors: thijs lg. Intensive Care Med. 1991;17(1):40-4. doi: 10.1007/BF01708408. Intensive Care Med. 1991. PMID: 1645378

8

Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: implications for septic shock.

Hack CE, Wagstaff J, Strack van Schijndel RJ, Eerenberg AJ, Pinedo HM, Thijs LG, Nuijens JH. Hack CE, et al. Among authors: thijs lg. Thromb Haemost. 1991 May 6;65(5):497-503. Thromb Haemost. 1991. PMID: 1871710

9

A model for the interplay of inflammatory mediators in sepsis--a study in 48 patients.

Hack CE, Nuijens JH, Strack van Schijndel RJ, Abbink JJ, Eerenberg AJ, Thijs LG. Hack CE, et al. Among authors: thijs lg. Intensive Care Med. 1990;16 Suppl 3:S187-91. doi: 10.1007/BF01709698. Intensive Care Med. 1990. PMID: 2289988 Review.

10

Proteolytic inactivation of plasma C1- inhibitor in sepsis.

Nuijens JH, Eerenberg-Belmer AJ, Huijbregts CC, Schreuder WO, Felt-Bersma RJ, Abbink JJ, Thijs LG, Hack CE. Nuijens JH, et al. Among authors: thijs lg. J Clin Invest. 1989 Aug;84(2):443-50. doi: 10.1172/JCI114185. J Clin Invest. 1989. PMID: 2668333 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page